Neutralizing antibodies and fatigue as predictors of low response to interferon-beta treatment in patients with multiple sclerosis. Manceau P, Latarche C, Pittion S, Edan G, De Sèze J, Massart C, Debouverie M BMC Neurol. 2014 Nov 30; 14(1):215. Epub 2014 Nov 30. PMID: 25433670. Abstract CommentRecommendBookmarkWatch